Alessio David Nahmad

3PUBLICATIONS
14CO-AUTHORS
Molecular targetsApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (3)

|Jun 30, 2022
Frequent aneuploidy in primary human T cells after CRISPR-Cas9 cleavage.

Alessio David Nahmad, Eli Reuveni, Ella Goldschmidt

|Jun 10, 2022
In vivo engineered B cells secrete high titers of broadly neutralizing anti-HIV antibodies in mice.

Alessio D Nahmad, Cicera R Lazzarotto, Natalie Zelikson

|Nov 18, 2020
Engineered B cells expressing an anti-HIV antibody enable memory retention, isotype switching and clonal expansion.

Alessio D Nahmad, Yuval Raviv, Miriam Horovitz-Fried

Pageof 1